| Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics J Kopeček Journal of Controlled Release 373, 1-22, 2024 | | 2024 |
| Human serum albumin-based drug-free macromolecular therapeutics induce apoptosis in chronic lymphocytic leukemia patient cells by crosslinking of CD20 and/or CD38 receptors J Li, MT Gambles, B Jones, JA Williams, NJ Camp, PJ Shami, J Yang, ... Drug Delivery and Translational Research, 1-13, 2024 | 1 | 2024 |
| Obinutuzumab‐Based Drug‐Free Macromolecular Therapeutics Synergizes with Topoisomerase Inhibitors MT Gambles, D Sborov, P Shami, J Yang, J Kopeček Macromolecular Bioscience 24 (3), 2300375, 2024 | 2 | 2024 |
| Development of Next Generation Antibody-Polymer-Drug Conjugates for Treatment of Multiple Myeloma J Li, MT Gambles, S Li, J Kopeček, D Sborov, J Yang Blood 142, 3308, 2023 | | 2023 |
| Antibody-polymer-drug conjugates J Yang, J Kopecek, L Zhang, Y Fang US Patent 11,801,307, 2023 | 3 | 2023 |
| Multi-targeted immunotherapeutics to treat B cell malignancies TM Gambles, J Yang, J Kopeček Journal of Ophthalmology Clinics and Research 358, 232-258, 2023 | 2 | 2023 |
| Bone fracture repair by targeting of agents that promote bone healing SA Low, PS Low, C Galliford, J Kopecek, J Yang US Patent 11,623,009, 2023 | | 2023 |
| Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo MT Gambles, J Li, DC Radford, D Sborov, P Shami, J Yang, J Kopeček Journal of Controlled Release 350, 584-599, 2022 | 9 | 2022 |
| Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model ZH Peng, CM Jogdeo, J Li, Y Xie, Y Wang, YM Sheinin, J Kopeček, ... Pharmaceutics 14 (8), 1725, 2022 | 3 | 2022 |
| Polymeric drug delivery conjugates and methods of making and using thereof J Yang, L Li, CM PETERSON, J Kopecek US Patent App. 17/754,915, 2022 | | 2022 |
| Compositions and methods for inducing apoptosis JH Kopecek, J Yang, TW Chu US Patent 11,213,540, 2022 | | 2022 |
| Nanomedicines in B cell-targeting therapies J Wang, J Yang, J Kopeček Acta biomaterialia 137, 1-19, 2022 | 16 | 2022 |
| Crosslinking of CD38 receptors triggers apoptosis of malignant B cells MT Gambles, J Li, J Wang, D Sborov, J Yang, J Kopeček Molecules 26 (15), 4658, 2021 | 12 | 2021 |
| Combination treatment with immunogenic and anti-PD-L1 polymer-drug conjugates of advanced tumors in a transgenic MMTV-PyMT mouse model of breast cancer L Li, J Wang, DC Radford, J Kopeček, J Yang Journal of Controlled Release 332, 652-659, 2021 | 10 | 2021 |
| Compositions and methods for using albumin-based nanomedicines JH Kopecek, J Yang US Patent 10,925,973, 2021 | 2 | 2021 |
| Dendronized polymer conjugates with amplified immunogenic cell death for oncolytic immunotherapy Y Li, L Li, J Wang, DC Radford, Z Gu, J Kopeček, J Yang Journal of Controlled Release 329, 1129-1138, 2021 | 14 | 2021 |
| IMMU-50. BBB CROSSING NANO-IMMUNOMEDICINE COMBINATION THERAPY TO TREAT BRAIN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA T Sun, J Yang, M Gamburg, V Ljubimov, Z Grodzinski, K Black, E Holler, ... Neuro-Oncology 22 (Supplement_2), ii115-ii115, 2020 | | 2020 |
| Bone fracture repair by targeting of agents that promote bone healing SA Low, PS Low, C Galliford, J Kopecek, J Yang US Patent 10,744,203, 2020 | 1 | 2020 |
| Nano-immuno combination therapy to treat brain primary central nervous system lymphoma T Sun, E Shatalova, O Braubach, D Klymyshyn, E Holler, J Wang, L Li, ... Cancer Research 80 (16_Supplement), 2869-2869, 2020 | | 2020 |
| Exploration and Evaluation of Therapeutic Efficacy of Drug‐Free Macromolecular Therapeutics in Collagen‐Induced Rheumatoid Arthritis Mouse Model J Wang, Y Li, L Li, J Yang, J Kopeček Macromolecular bioscience 20 (5), 1900445, 2020 | 9 | 2020 |
Zheng-Rong LuCase Western Reserve University在 case.edu 的电子邮件经过验证
